1142 related articles for article (PubMed ID: 33732263)
1. Multipotent Mesenchymal Stromal Cells in Rheumatoid Arthritis and Systemic Lupus Erythematosus; From a Leading Role in Pathogenesis to Potential Therapeutic Saviors?
El-Jawhari JJ; El-Sherbiny Y; McGonagle D; Jones E
Front Immunol; 2021; 12():643170. PubMed ID: 33732263
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem Cell Therapy: Hope for Patients With Systemic Lupus Erythematosus.
Li A; Guo F; Pan Q; Chen S; Chen J; Liu HF; Pan Q
Front Immunol; 2021; 12():728190. PubMed ID: 34659214
[TBL] [Abstract][Full Text] [Related]
3. Mesenchymal Stem/Stromal Cells for Rheumatoid Arthritis Treatment: An Update on Clinical Applications.
Lopez-Santalla M; Fernandez-Perez R; Garin MI
Cells; 2020 Aug; 9(8):. PubMed ID: 32784608
[TBL] [Abstract][Full Text] [Related]
4. The immunomodulatory effects of mesenchymal stromal cell-based therapy in human and animal models of systemic lupus erythematosus.
Radmanesh F; Mahmoudi M; Yazdanpanah E; Keyvani V; Kia N; Nikpoor AR; Zafari P; Esmaeili SA
IUBMB Life; 2020 Nov; 72(11):2366-2381. PubMed ID: 33006813
[TBL] [Abstract][Full Text] [Related]
5. Neutrophils in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus: Same Foe Different M.O.
Fresneda Alarcon M; McLaren Z; Wright HL
Front Immunol; 2021; 12():649693. PubMed ID: 33746988
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells, autoimmunity and rheumatoid arthritis.
El-Jawhari JJ; El-Sherbiny YM; Jones EA; McGonagle D
QJM; 2014 Jul; 107(7):505-14. PubMed ID: 24518000
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory Effect of MSCs and MSCs-Derived Extracellular Vesicles in Systemic Lupus Erythematosus.
Yang C; Sun J; Tian Y; Li H; Zhang L; Yang J; Wang J; Zhang J; Yan S; Xu D
Front Immunol; 2021; 12():714832. PubMed ID: 34603289
[TBL] [Abstract][Full Text] [Related]
8. Functional Characteristics and Application of Mesenchymal Stem Cells in Systemic Lupus Erythematosus.
Tang WY; Liu JH; Peng CJ; Liao Y; Luo JS; Sun X; Tang YL; Luo XQ
Arch Immunol Ther Exp (Warsz); 2021 Mar; 69(1):7. PubMed ID: 33713197
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of mesenchymal stem cells on systemic lupus erythematosus:a meta-analysis].
Liu S; Guo YL; Yang JY; Wang W; Xu J
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1014-1021. PubMed ID: 30562774
[TBL] [Abstract][Full Text] [Related]
10. Are mesenchymal stem cells in rheumatoid arthritis the good or bad guys?
De Bari C
Arthritis Res Ther; 2015 May; 17(1):113. PubMed ID: 25929877
[TBL] [Abstract][Full Text] [Related]
11. Modulation of Mesenchymal Stem Cells-Mediated Adaptive Immune Effectors' Repertoire in the Recovery of Systemic Lupus Erythematosus.
Hoseinzadeh A; Rezaieyazdi Z; Afshari JT; Mahmoudi A; Heydari S; Moradi R; Esmaeili SA; Mahmoudi M
Stem Cell Rev Rep; 2023 Feb; 19(2):322-344. PubMed ID: 36272020
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cells for the management of rheumatoid arthritis: immune modulation, repair or both?
Ansboro S; Roelofs AJ; De Bari C
Curr Opin Rheumatol; 2017 Mar; 29(2):201-207. PubMed ID: 27941390
[TBL] [Abstract][Full Text] [Related]
13. Dysregulated balance in Th17/Treg axis of Pristane-induced lupus mouse model, are mesenchymal stem cells therapeutic?
Hoseinzadeh A; Rezaieyazdi Z; Mahmoudi M; Tavakol Afshari J; Lavi Arab F; Esmaeili SA; Faridzadeh A; Rezaeian A; Hoseini S; Barati M; Mahmoudi A; Sadat Tabasi N
Int Immunopharmacol; 2023 Apr; 117():109699. PubMed ID: 36867923
[TBL] [Abstract][Full Text] [Related]
14. Lupus mice derived mesenchymal stromal cells: Beneficial or detrimental on SLE disease outcome.
Hosseini S; Mahmoudi M; Rezaieyazdi Z; Shapouri-Moghaddam A; Hosseinzadeh A; Arab FL; Tabasi NS; Esmaeili SA
Int Immunopharmacol; 2024 Jan; 126():111306. PubMed ID: 38039717
[TBL] [Abstract][Full Text] [Related]
15. Mesenchymal Stem Cell Therapy for Autoimmune Disease: Risks and Rewards.
Munir H; McGettrick HM
Stem Cells Dev; 2015 Sep; 24(18):2091-100. PubMed ID: 26068030
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulatory Effects of Mesenchymal Stem Cells and Mesenchymal Stem Cell-Derived Extracellular Vesicles in Rheumatoid Arthritis.
Liu H; Li R; Liu T; Yang L; Yin G; Xie Q
Front Immunol; 2020; 11():1912. PubMed ID: 32973792
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effect of human bone marrow-derived mesenchymal stromal/stem cells on peripheral blood T cells from rheumatoid arthritis patients.
Pedrosa M; Gomes J; Laranjeira P; Duarte C; Pedreiro S; Antunes B; Ribeiro T; Santos F; Martinho A; Fardilha M; Domingues MR; Abecasis M; P da Silva JA; Paiva A
J Tissue Eng Regen Med; 2020 Jan; 14(1):16-28. PubMed ID: 31502378
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal cells and rheumatic disorders.
Tyndall A
Immunol Lett; 2015 Dec; 168(2):201-7. PubMed ID: 26142543
[TBL] [Abstract][Full Text] [Related]
19. Interactions of mesenchymal stromal/stem cells and immune cells following MSC-based therapeutic approaches in rheumatoid arthritis.
Dehnavi S; Sadeghi M; Tavakol Afshari J; Mohammadi M
Cell Immunol; 2023; 393-394():104771. PubMed ID: 37783061
[TBL] [Abstract][Full Text] [Related]
20. miRNA-146a Improves Immunomodulatory Effects of MSC-derived Exosomes in Rheumatoid Arthritis.
Tavasolian F; Hosseini AZ; Soudi S; Naderi M
Curr Gene Ther; 2020; 20(4):297-312. PubMed ID: 32938348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
